Compound Detail
CHEMBL4443174
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4443174 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZGWABBAGISWEDK-FNXZNAJJSA-N |
| Parent Compound | CHEMBL4594648 |
| Active Moiety | CHEMBL4594648 |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
302.4
MW (Da)
2.17
ALogP
4
HBA
2
HBD
70.1
PSA (Ų)
0.38
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.09
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 5.09 | 5.09 | 8060.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.94 | 4.94 | 11500.0 | 1 |
| Leishmania infantum CHEMBL612848 | IC50 | 4.69 | 4.69 | 20300.0 | 1 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 4.55 | 4.55 | 28000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Trypanosoma brucei rhodesiense | IC50 | = | 8060.0 | nM | 5.09 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 assess... | 30638761 |
| Trypanosoma cruzi | IC50 | = | 11500.0 | nM | 4.94 | Antitrypanosomal activity against beta-galactosidase expressing nifurtimox-sensi... | 30638761 |
| Leishmania infantum | IC50 | = | 20300.0 | nM | 4.69 | Antileishmanial activity against amastigote stage of Leishmania infantum MHOM/MA... | 30638761 |
| Trypanosoma brucei | IC50 | = | 28000.0 | nM | 4.55 | Antitrypanosomal activity against suramin-sensitive Trypanosoma brucei Squib 427... | 30638761 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30638761 | 10.1016/j.bmc.2019.01.002 | Escherichia coli | 2 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Mycobacterium tuberculosis | 2 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Pseudomonas aeruginosa | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Staphylococcus aureus | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Candida albicans | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Trypanosoma cruzi | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Trypanosoma brucei | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Trypanosoma brucei rhodesiense | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Leishmania infantum | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Unchecked | 1 |
| 30638761 | 10.1016/j.bmc.2019.01.002 | Staphylococcus epidermidis | 1 |
Data from ChEMBL 36 via Core Engine